EUVIMEDEUVIMED entdecken
Open Access

Chronic late gestation fetal hyperglucagonaemia results in lower insulin secretion, pancreatic mass, islet area and beta‐ and α‐cell proliferation

Sarah N Cilvik iD, Brit Boehmer, Stephanie R Wesolowski iD, Laura D Brown, Paul J Rozance iD

The Journal of Physiology · 2024-11 · 602 (22) · 6329-6345

DOI: 10.1113/jp286974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, online erschienen am 09.10.2024. Verfasst von Sarah N Cilvik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Perinatal Research Center, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Hauptthemen laut MEDLINE: Glucagon, Glucagon-Secreting Cells, Insulin, Insulin-Secreting Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NICHD NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fetal glucagon concentrations are elevated in the presence of a compromised intrauterine environment, as in cases of placental insufficiency and perinatal acidaemia. Our objective was to investigate the impact of late gestation fetal hyperglucagonaemia on in vivo insulin secretion and pancreatic islet structure. Chronically catheterized late gestation fetal sheep received an intravenous infusion of glucagon at low (5 ng/kg/min; GCG‐5) or high (50 ng/kg/min; GCG‐50) concentrations or a vehicle control (CON) for 8–10 days. Glucose‐stimulated fetal insulin secretion (GSIS) was measured following 3 h (acute response) and 8–10 days (chronic response) of experimental infusions. Insulin, glucose and amino acid concentrations were measured longitudinally. The pancreas was collected at the study end for histology and gene expression analysis. Acute exposure (3 h) to GCG‐50 induced a 3‐fold increase in basal insulin concentrations with greater GSIS. Meanwhile, chronic exposure to both GCG‐5 and GCG‐50 decreased basal insulin concentrations 2‐fold by day 8–10. Chronic GCG‐50 also blunted GSIS at the study end. Fetal amino acid concentrations were decreased within 24 h of GCG‐5 and GCG‐50, while there were no differences in fetal glucose. Histologically, GCG‐5 and GCG‐50 had lower β‐ and α‐cell proliferation, as well as lower α‐cell mass and pancreas weight, while GCG‐50 had lower islet area. This study demonstrates that chronic glucagon elevation in late gestation fetuses impairs β‐cell proliferation and insulin secretion, which has the potential to contribute to later‐life diabetes risk. We speculate that the action of glucagon in lower circulating fetal amino acid concentrations may have a suppressive effect on insulin secretion. image Key points We have previously demonstrated in a chronically catheterized fetal sheep model that experimentally elevated glucagon in the fetus impairs placental function, reduces fetal protein accretion and lowers fetal weight. In the present study, we further characterized the effects of elevated fetal glucagon on fetal physiology with a focus on pancreatic development and β‐cell function. We show that experimentally elevated fetal glucagon results in lower β‐ and α‐cell proliferation, as well as decreased insulin secretion after 8−10 days of glucagon infusion. These results have important implications for β‐cell reserve and later‐life predisposition to diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucagonGlucagon-Secreting CellsInsulinInsulin-Secreting CellsCell ProliferationInsulin SecretionAnimalsPregnancyFemaleSheepFetusIslets of LangerhansPancreasGlucose

Stichwörter der Autor:innen

alpha‐cellbeta‐cellfetal pancreasglucagonglucose‐stimulated insulin secretion

Substanzen

GlucagonInsulinGlucose

Autor:innen und Institutionen

  • Perinatal Research Center, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

ORCID-Profile: Sarah N Cilvik, Stephanie R Wesolowski, Paul J Rozance

Förderung

  • NIDDK NIH HHS
  • NICHD NIH HHS
  • NIH HHS
  • NHLBI NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • NIH Office of the Director
  • American Academy of Pediatrics

Zitieren

APA

Cilvik, S. N., Boehmer, B., Wesolowski, S. R., Brown, L. D., & Rozance, P. J. (2024). Chronic late gestation fetal hyperglucagonaemia results in lower insulin secretion, pancreatic mass, islet area and beta‐ and α‐cell proliferation. The Journal of Physiology, 602(22), 6329-6345. https://doi.org/10.1113/jp286974

Vancouver

Cilvik SN, Boehmer B, Wesolowski SR, Brown LD, Rozance PJ. Chronic late gestation fetal hyperglucagonaemia results in lower insulin secretion, pancreatic mass, islet area and beta‐ and α‐cell proliferation. The Journal of Physiology. 2024;602(22):6329-6345. doi:10.1113/jp286974

BibTeX
@article{Cilvik2024,
  author = {Cilvik, Sarah N and Boehmer, Brit and Wesolowski, Stephanie R and Brown, Laura D and Rozance, Paul J},
  title = {Chronic late gestation fetal hyperglucagonaemia results in lower insulin secretion, pancreatic mass, islet area and beta‐ and α‐cell proliferation},
  journal = {The Journal of Physiology},
  year = {2024},
  volume = {602},
  number = {22},
  pages = {6329--6345},
  doi = {10.1113/jp286974}
}
Kostenlos starten →